Loading...
Loading...
PEARW| Name | Value |
|---|---|
| Revenues | 3.3M |
| Cost of Revenue | 2.4M |
| Gross Profit | 0.9M |
| Operating Expense | 33.7M |
| Operating I/L | -32.8M |
| Other Income/Expense | 38.3M |
| Interest Income | 0.0M |
| Pretax | 5.5M |
| Income Tax Expense | -38.3M |
| Net Income/Loss | 43.7M |
Pear Therapeutics, Inc. specializes in developing and commercializing software-based medicines for severe psychiatric and neurologic conditions. Their products include PearConnect, a patient service center for prescription digital therapeutics; reSET for substance use disorder treatment; reSET-O for opioid use disorder treatment; and Somryst for chronic insomnia treatment.
